Hostname: page-component-586b7cd67f-tf8b9 Total loading time: 0 Render date: 2024-11-24T07:58:48.425Z Has data issue: false hasContentIssue false

Ondansetron, droperidol and their combination for the prevention of post-operative vomiting in children

Published online by Cambridge University Press:  16 August 2006

A. Klockgether-Radke
Affiliation:
Department of Anaesthesiology, Emergency Medicine and Intensive Care, Georg-August-University of Göttingen, Göttingen, Germany
S. Neumann
Affiliation:
Department of Anaesthesiology, Emergency Medicine and Intensive Care, Georg-August-University of Göttingen, Göttingen, Germany
P. Neumann
Affiliation:
Department of Anaesthesiology, Emergency Medicine and Intensive Care, Georg-August-University of Göttingen, Göttingen, Germany
U. Braun
Affiliation:
Department of Anaesthesiology, Emergency Medicine and Intensive Care, Georg-August-University of Göttingen, Göttingen, Germany
H. Mühlendyck
Affiliation:
Department of Strabology and Neuroophthalmology, Georg-August-University of Göttingen, Göttingen, Germany
Get access

Abstract

In this study the antiemetic effects of droperidol, ondansetron and their combination were evaluated in 160 ASA Grade I and II children undergoing surgery for strabismus, who were randomly assigned to one of four groups: Group D received droperidol 75 μg kg−1, group O ondansetron 0.1 mg kg−1, group D + O received both droperidol 75 μg kg−1 and ondansetron 0.1 mg kg−1, and group N NaCl as placebo. Emesis within the first 24 h occurred in 95.0% of the children with placebo medication, compared with 32.5% (D), 40.0% (O) and 45.0% (D + O) in the groups with antiemetic prophylaxis. The differences between group N and all other groups were significant (P < 0.001). However, there were no statistically significant differences between the groups D, O and D + O. It is concluded that droperidol (75 μg kg−1) and ondansetron (0.1 mg kg−1) both significantly reduce PONV in children undergoing surgery for strabismus. Neither ondansetron, nor the combination D+O were superior to droperidol alone.

Type
Original Article
Copyright
1997 European Society of Anaesthesiology

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)